Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Assist. Prof. Dr. Jing-Da Qiao, Guangzhou Medical University, China

Jingda Qiao is a dedicated biomedical researcher with a multidisciplinary background in pharmaceutical engineering, neuroscience, and biomedical science. He holds a Bachelor’s degree in Pharmaceutical Engineering from Guangzhou University of Chinese Medicine, a Master’s degree in Neuroscience from Zhongshan School of Medicine at Sun Yat-sen University under the supervision of Prof. Huaiyu Gu, and a Ph.D. in Biomedical Science from The Chinese University of Hong Kong, mentored by Professors Wing-Ho Yung and Ya Ke. Jingda’s research focuses on the pathogenesis and treatment of neurodevelopmental disorders, combining genome-wide sequencing with transgenic animal models such as mice and Drosophila to investigate novel disease-related genes. He is also actively engaged in exploring the mechanisms of learning, memory, and neural plasticity using electrophysiology, live imaging, and behavioral analysis. His technical expertise spans electrophysiology, molecular biology, behavioral neuroscience, and analytical chemistry. Recognized for his academic excellence, Jingda has received prestigious honors including the Guangdong Overseas Postdoctoral Fellowship and selection as a Young Talent under Guangzhou’s Senior Ranking Personnel Program.

Professional Profile:

ORCID

🏅 Summary of Suitability for Best Researcher Award 

Dr. Jingda Qiao is a multidisciplinary biomedical scientist with strong academic foundations and hands-on expertise in neuroscience, biomedical science, and analytical chemistry. With advanced training across prestigious institutions in China and Hong Kong, his work bridges molecular, cellular, and behavioral neuroscience—making him a highly suitable candidate for the Best Researcher Award.

🎓 Education

  • 🧪 Bachelor of Engineering
    Major: Pharmaceutical Engineering
    Institution: Guangzhou University of Chinese Medicine

  • 🧠 Master of Science
    Major: Neuroscience
    Institution: Zhongshan School of Medicine, Sun Yat-sen University
    Supervisor: Prof. Huaiyu Gu

  • 🔬 Doctor of Philosophy (Ph.D.)
    Major: Biomedical Science
    Institution: The Chinese University of Hong Kong
    Supervisors: Prof. Wing-Ho Yung and Prof. Ya Ke

🧪 Research Experience & Skills

  • 🔋 Electrophysiology: Patch clamp (whole-cell), brain slice & in vivo LTP

  • 🧬 Molecular Biology: PCR, Western blot, ELISA, flow cytometry, paraffin sectioning

  • 🧠 Behavioral Studies: Rodent & Drosophila models for seizure, learning, memory

  • ⚗️ Analytical Chemistry: GC-MS, HPLC, TOF-MS, UV-Vis, gel filtration, membrane separation

  • 🔍 Microscopy: Laser scanning confocal & scanning electron microscopy

💡 Research Interests

  1. 🧠 Neurodevelopmental Disorders:

    • Gene identification via trio-based genome-wide sequencing

    • Use of transgenic mice and Drosophila to uncover disease mechanisms

  2. 🧠 Learning & Memory Mechanisms:

    • Applying electrophysiology, live imaging, and behavior analysis

    • Investigating synaptic plasticity and neural circuits involved in cognition

🏅 Honors & Awards

  • 🌍 Guangdong Overseas Postdoc Program
    (广东省海外青年博士后引进计划)

  • 🌟 Guangzhou High-Level Talent – Youth Reserve Talent
    (广州市高层次人才 青年后备人才)

Publication Top Notes:

Investigation of epilepsy-related genes in a Drosophila model

<i>ZFHX3</i> variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

Identification of novel pathogenic genes of childhood epileptic encephalopathies

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency

The Interaction ofUBR4, LRP1, andOPHN1in Refractory Epilepsy:DrosophilaModel to Investigate the Oligogenic Effect on Epilepsy

Iodine Acetonitrile as a Drinking Water Disinfectant Showed a Potential Toxic Effect on Organism

 

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang, Peking university, China

Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Anmin Huang

Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.

🎓 Education & Work Experience

  • Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology

  • Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma

🏆 Achievements

  • Research Publications 📚

    • Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering

    • Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis

    • Contributed to the study of tumor immune infiltration and immunotherapy response

  • Patents & Innovations 🧪

    • Holder of two utility model patents for laboratory equipment

    • Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy

    • Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method

🎖 Awards & Honors

  • Recognized for cutting-edge research in oncology and immunotherapy

  • Contributions to novel cancer treatment strategies and immune regulation

Publication Top Notes:

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites